---
$id: https://graph.org.ai/products/commodity/51161547
$type: Product
source: UNSPSC
code: "51161547"
title: "Motapizone"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Motapizone

**UNSPSC Code**: 51161547
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C12H12N4OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C4A61P8A37, chemically known as 3(2h)-pyridazinone, 4,5-dihydro-6-(4-imidazol-1-yl-2-thienyl)-5-methyl- but generally known as motapizone, which bears US NIH Compound Identifier 65819. European Medicines Agency schedules Motapizone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09075MIG. The term MOTAPIZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). MOTAPIZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule motapizone under HS 29349990 and SITC 51579. As of Q4 2014, MOTAPIZONE remains the US FDA Preferred Term for this commodity. Motapizone bears US NLM identifiers UMLS ID C0066826 and NCI Concept Code C66205. SMILES: CC1CC(=O)NN=C1C2=CC(=CS2)N3C=CN=C3.

